Treatment of trigger finger

Treatment of trigger finger: a randomized clinical trial comparing the methods of corticosteroid injection and percutaneous release

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180627040252N1

Enrollment

Registered

2019-12-19

Start date

2018-07-11

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger finger. Trigger finger

Interventions

Intervention 1: Intervention group: First with lidocaine 2% local anesthesia is performed and then the needle of the gage 18 is inserted through the anatomical site and attempts to release percutaneo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Patients with informed consent Patients with trigger finger symptoms based on the QUINNELL scale. Patients with no history of any previous finger surgery

Exclusion criteria

Exclusion criteria: Patients with hand tendon disorders

Design outcomes

Primary

Measure	Time frame
Assessing the finger movement. Timepoint: Weeks 1, 3 and 6 and then 3 and 6 months after intervention. Method of measurement: Physical examination.	—

Secondary

Measure	Time frame
Pain after surgery. Timepoint: 1, 3 and 6 weeks and then 3 to 6 months after intervention. Method of measurement: Visual Analogue Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Abdoli Tafti

Yazd University of Medical Sciences

aabdoli2000@mail.ssu.ac.ir+98 35 3822 9008

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026